Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Pathophysiology, Morbidity, and Mortality of Obstructive Sleep Apnea.

Journal of insurance medicine (New York, N.Y.)·2024
Same author

Recurrent injury patterns in adolescent rugby.

Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine·2018
Same author

Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy.

Leukemia·2016
Same author

Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome.

Leukemia·2016
Same author

The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.

Oncogene·2016
Same author

RISUS study: Rugby Injury Surveillance in Ulster Schools.

British journal of sports medicine·2015

Related Experiment Video

Updated: Jul 20, 2026

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

Effects of chronic amorphous silica exposure on sequential pulmonary function.

R K Wilson, P M Stevens, H B Lovejoy

    Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
    |June 1, 1979
    PubMed
    Summary

    Precipitated amorphous silica (PAS) exposure did not adversely affect lung function or cause pneumoconiosis in workers. Respiratory symptoms were linked to smoking, not silica exposure, indicating low occupational risk.

    More Related Videos

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
    05:03

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

    Published on: October 28, 2022

    A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
    10:45

    A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

    Published on: January 6, 2023

    Related Experiment Videos

    Last Updated: Jul 20, 2026

    An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
    09:29

    An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

    Published on: May 13, 2020

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
    05:03

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

    Published on: October 28, 2022

    A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
    10:45

    A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

    Published on: January 6, 2023

    Area of Science:

    • Occupational Health
    • Pulmonary Medicine
    • Materials Science

    Background:

    • Precipitated amorphous silica (PAS) is used in various industrial applications.
    • Understanding the long-term respiratory effects of occupational PAS exposure is crucial for worker safety.

    Purpose of the Study:

    • To evaluate the clinical effects of long-term precipitated amorphous silica exposure on respiratory health in industrial workers.

    Main Methods:

    • Review of spirometry, respiratory questionnaires, and chest radiographs from 165 PAS-exposed workers.
    • Calculation of cumulative exposure index (CEI) and mean exposure index (MEI).
    • Linear regression analysis to assess correlations between exposure levels and pulmonary function changes.

    Main Results:

    • No adverse effects on pulmonary function variables (FVC, FEV1) were correlated with PAS exposure (CEI or years).
    • Respiratory symptoms like cough and dyspnea correlated with smoking history, not PAS exposure.
    • No radiographic evidence of pneumoconiosis was found in workers exposed solely to PAS.

    Conclusions:

    • Long-term occupational exposure to precipitated amorphous silica does not appear to cause significant adverse effects on lung function or lead to pneumoconiosis.
    • Smoking remains a significant factor influencing respiratory symptoms in workers, independent of silica exposure.